Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: Lilly ICOS LLC | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Financial Report: Lilly ICOS LLC

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Lilly ICOS LLC

4Q Revenues: $226.7 million (+30%)

4Q Earnings: $99.9 million (+63%)

FY Revenues: $800.9 million (+31%)

FY Earnings: $320.3 million (earnings were $37.8 million FY2006)

Comments: Revenue for the quarter includes $12 million in royalties on sales reported by Lilly, compared to $9 million in 4Q2005. FY revenue includes $45.7 million in royalties on sales reported by Lilly, compared to $34 million in 4Q2005. FY earnings reflect a $224.4 million increase in worldwide sales of Cialis and a $96.8 million reduction in selling, general and administrative costs. The acquisition of ICOS by Eli Lilly and Co., announced in December 2006, is expected to close early in 1Q2007.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters